Lineage, Inc.
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Derivative instruments and hedging activities
(9)Derivative instruments and hedging activities
(a)Risk management objective of using derivatives
The Company manages certain economic risks, including interest rate, foreign currency, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and with the use of derivative financial instruments.
(b)Cash flow hedges of interest rate and foreign currency risk
The Company’s objectives in using interest rate derivatives are to manage its exposure to interest rate movements and to mitigate the potential volatility to interest expense. To accomplish this objective, the Company primarily uses interest rate swaps and caps as part of its interest rate risk management strategy. Interest rate swaps involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for a premium. The Company’s designated interest rate swaps and caps hedge variable-rate interest payments using a first payments approach. The first payments approach allows an entity to hedge interest payments on a designated principal amount, rather than a specific, named debt issuance.
In addition, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future cash amounts due to changes in foreign currency rates. The impacts of these foreign currency derivative instruments on the condensed consolidated financial statements of the Company are insignificant.
(c)Designated hedges - interest rate contracts
As of March 31, 2025, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedging instruments.
| Number of Instruments · Notional | |||
|---|---|---|---|
| Interest rate derivatives: · (in millions) | |||
| Interest rate swap | 3 | USD | 1,000 |
| Interest rate cap | 3 | USD | 1,500 |
| Total | 6 | USD | 2,500 |
The table below presents the effect of the Company’s interest rate derivatives that are designated as hedging instruments in the condensed consolidated statements of operations and comprehensive income (loss) (in millions). Gain (loss) reclassified from accumulated other comprehensive income (“AOCI”) into earnings for interest rate contracts is presented in Interest expense, net.
| Interest Rate Derivatives in Cash Flow Hedging Relationships · Amount of Gain (Loss) Recognized in OCI on Derivatives · Amount of Gain (Loss) Reclassified from AOCI into Earnings | ||||
|---|---|---|---|---|
| Three Months Ended March 31, | Three Months Ended March 31, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Included in effectiveness testing | $1 | $32 | $19 | $26 |
| Excluded from effectiveness testing and recognized in earnings based on an amortization approach | — | (3) | — | (1) |
| Total | $1 | $29 | $19 | $25 |
The estimated net amount of existing gains (losses) that are reported in Accumulated other comprehensive income (loss) as of March 31, 2025 that is expected to be reclassified into earnings within the next 12 months is $51 million.
(d)Balance sheet presentation - interest rate contracts
The Company’s interest rate derivative contracts had a fair value of $51 million and $69 million as of March 31, 2025 and December 31, 2024, respectively, and were classified in Other assets in the condensed consolidated balance sheets. Refer to Note 11, Fair value measurements for further information on the valuation of the Company’s derivatives.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.